PATENT CLAIM ANALYSIS

Application Number: 15915987
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["435", "006100"]

Abstract:
The present invention relates to the field of pharmacogenomics and in particular to detecting the presence or absence of hypermethylated DNA. The detection of CpG methylation in marker DNA is useful for the diagnosis of cancers and the invention provides improved methods for this purpose. These improved methods allow in particular for a more sensitive detection of methylated marker DNA with high backgrounds of unmethylated marker DNA.

Claim (Index 28):
The kit of  claim 23 , wherein the methylation-specific blocker consists of the nucleic acid sequence of SEQ ID NO: 123.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 90.0
- Lexical Diversity: 1.62791
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15436436', '09887941', '11415322', '12848239', '11630620']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6786009778995895
- 35 USC 102 Novelty (BERT): 0.6725012061297452
- Combined Prediction Score: 0.6779910007226051
- Mean Citation Score: 465.561808
- Max Citation Score: 766.7551
- Similarity Product: 640.5543745189487

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test